Solu-Medrol 1g powder for injection vial with diluent vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

methylprednisolone sodium succinate, Quantity: 1.326 g (Equivalent: methylprednisolone, Qty 1 g)

から入手可能:

Pfizer Australia Pty Ltd

医薬品形態:

Injection, powder for

構図:

Excipient Ingredients: monobasic sodium phosphate monohydrate; dibasic sodium phosphate; sodium hydroxide

投与経路:

Intravenous, Intramuscular, Rectal

パッケージ内のユニット:

1 vial of diluent - 15.6mL, 1 vial of powder - 1g

クラス:

Medicine Registered

処方タイプ:

Not scheduled. Not considered by committee, (S4) Prescription Only Medicine

適応症:

When oral therapy is not feasible and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, SOLU-MEDROL Powder for Injection is indicated only for intravenous or intramuscular use in the following conditions:,Endocrine Disorders,? Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogues may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance).,? Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogues are used).,? Preoperatively and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful.,? Shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected.,? C

製品概要:

Visual Identification: White freeze dried cake in vial of powder, colourless diluent in separate vial.;

認証ステータス:

Registered

承認日:

1991-08-02

情報リーフレット

SOLU-MEDROL
®
S
O
L
U
-
M
E
D
R
O
L
®
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I GIVEN SOLU-MEDROL?
SOLU-MEDROL contains the active ingredient methylprednisolone sodium
succinate. SOLU-MEDROL is used for treatment of
various medical conditions including skin diseases, allergic
reactions, inflammation of the eyes, respiratory diseases and certain
respiratory infections, diseases of the gut, multiple sclerosis,
rheumatic disorders, diseases of the blood and treatment of certain
glandular conditions. For more information, see Section 1. Why am I
given SOLU-MEDROL? in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I RECEIVE SOLU-MEDROL?
Do not use if you have ever had an allergic reaction to
methylprednisolone sodium succinate or any of the ingredients listed
at the
end of the CMI. Talk to your doctor if you have any other medical
conditions, take any other medicines, or are pregnant or plan to
become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I
receive SOLU-MEDROL? in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines and food may interfere with SOLU-MEDROL and affect how
it works. Tell your doctor if you are taking any other
medicines including medicines used to relieve pain or swelling, some
antibiotics, oral contraceptives, anticoagulants, anticonvulsants
and antidiabetic medicines.
A list of these medicines is in Section 3. What if I am taking other
medicines? in the full CMI.
4.
HOW IS SOLU-MEDROL GIVEN?
This medicine will be administered under medical supervision.
SOLU-MEDROL must be administered by intravenous or
intramuscular injection. You must not administer this medicine to
yourself.
The dose, how often and how long you are treated with SOLU-MEDROL will
depend on your medical condition and also on your
weight. Your doctor may change the dose and how many times a day you
have it, as your condition ch

製品の特徴

Version: pfpsolmv11221
Supersedes: pfpsolmv10321
Page 1 of 30
AUSTRALIAN
PRODUCT
INFORMATION
–
SOLU-MEDROL
®
AND
SOLU-MEDROL
ACT-O-VIAL
®
(METHYLPREDNISOLONE
SODIUM SUCCINATE)
1.
NAME OF THE MEDICINE
Methylprednisolone sodium succinate
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
SOLU-MEDROL is available in several strengths for intravenous (IV) or
intramuscular (IM)
administration.
40 MG ACT-O-VIAL SYSTEM
- Each mL (when mixed) contains methylprednisolone sodium
succinate equivalent to 40 mg methylprednisolone;
125 MG ACT-O-VIAL SYSTEM
- Each 2 mL (when mixed) contains methylprednisolone
sodium succinate equivalent to 125 mg methylprednisolone;
500 MG VIAL WITH DILUENT
- Each 8 mL (when mixed as directed) contains
methylprednisolone sodium succinate equivalent to 500 mg
methylprednisolone;
1 G VIAL WITH DILUENT
- Each 15.6 mL (when mixed as directed) contains methylprednisolone
sodium succinate equivalent to 1 g methylprednisolone;
2 G VIAL WITH DILUENT
- Each 31.2 mL (when mixed as directed) contains methylprednisolone
sodium succinate equivalent to 2 g methylprednisolone;
500 MG PLAIN VIAL
- Each vial contains methylprednisolone sodium succinate equivalent to
500 mg methylprednisolone;
1 G PLAIN VIAL
- Each vial contains methylprednisolone sodium succinate equivalent to
1 g
methylprednisolone;
For the full list of excipients, see Section 6.1 List of excipients.
3.
PHARMACEUTICAL FORM
SOLU-MEDROL 40 mg and 125 mg ACT-O-VIAL System
-
Powder for injection: White freeze dried cake
_ _
-
Diluent: Clear colourless liquid
_ _
SOLU-MEDROL 500 mg, 1 g and 2 g Vials with Diluent
-
Powder for injection: White freeze dried cake
_ _
Version: pfpsolmv11221
Supersedes: pfpsolmv10321
Page 2 of 30
-
Diluent: Clear colourless liquid
_ _
SOLU-MEDROL 500 mg and 1 g Plain Vials
-
Powder for injection: White freeze dried cake
When necessary, the pH of each formula was adjusted with sodium
hydroxide so that the pH
of the reconstituted solution is within the USP specified range of 7
to 8 and the tonicities are,
for the 40 mg per m